Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
Related Posts
Rodriguez LA, Yassin M, Duru OK, Neugebauer RS, Brown SD, Castellon-Lopez Y, Thomas TW, Schmittdiel JA. Changes in diabetes screening and exercise during the COVID-19[...]
Ikesu R, Gotanda H, Russell TA, Maggard-Gibbons M, Russell MM, Yoshida R, Li R, Klomhaus A, de Virgilio C, Tsugawa Y. Long-Term Postoperative Outcomes by[...]
La Charite J, DeCamp LR, Prichett L, Finney AG, Chen JY, Holler AE, Moon YJ, Mullins A, Ospino R, Rodriguez KP, Polk S. Two-Year Outcomes[...]